Clinical Trial Update: The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of combining Iparomlimab and Tuvonralimab with chemotherapy as first-line treatment for Esophageal Squ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 2 | Status: RECRUITING